| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |